Find clinical trials for ovarian cancer. Search for ovarian cancer clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 341
Active & Responsive
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
for
Ovarian Cancer
Location: Miami FL, Des Moines IA, Morristown NJ, Rochester NY,
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 50 - 70+
Code: NCT00539162
Recruiting
Active & Responsive
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Santa Rosa CA, Hartford CT, Washington D.C. DC,
Sponsor: VM Oncology, LLC
Sex: All
Age: 18 - 70+
Code: NCT03556228
Phase1, Recruiting
Active & Responsive
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies
Location: Los Angeles CA, Louisville KY, Houston TX
Sponsor: Portage Biotech
Sex: All
Age: 18+
Code: NCT04969315
Phase1, Phase2, Recruiting
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
for
Ovarian Cancer
Location: Annapolis MD
Sponsor: NX Development Corp
Sex: Female
Age: 18+
Code: NCT05804370
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Scottsdale AZ, Jacksonville FL, Rochester MN, New York NY,
Sponsor: GI Innovation, Inc.
Sex: All
Age: 18+
Code: NCT05824975
Phase1, Phase2, Recruiting
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
for
Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer,